Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

Research stocks

Ready to invest in the medical industry? Consider these 11 stocks.

The best research stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.

11 research stocks to watch

We round up a selection of stocks in or related to the medical industry, weighting the list more heavily towards popular mid- and large-cap US stocks.

  1. Biocept (BIOC)
  2. Opko Health (OPK)
  3. Natera (NTRA)
  4. Danaher Corporation (DHR)
  5. IDEXX Laboratories (IDXX)
  6. Co-Diagnostics (CODX)
  7. DexCom (DXCM)
  8. Laboratory Corporation of America (LH)
  9. Agilent Technologies (A)
  10. Illumina (ILMN)
  11. Thermo Fisher Scientific (TMO)

Compare trading platforms

Compare online trading platforms by fees, asset types and bonuses to find the best for your investment in research stocks.
1 - 7 of 7
Name Product Available asset types Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get $15
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
N/A
Winner of Finder’s Best Overall Stock Broker award.
Finder Award
Webull
Stocks, Options, ETFs, Cryptocurrency
Get up to 12 free stocks valued up to $30,600
when you open an account and make a deposit. T&Cs apply.
A beginner-friendly broker that offers paper trading, so you can try the platform before depositing funds.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Take a deeper dive into research stocks

If you're interested in investing in the medical industry, take a closer look at what companies in this industry do and how the stocks have historically performed. Keep in mind that positive past performance doesn't guarantee that a stock will continue to rise in the future.

1. Biocept (BIOC)

Biocept, Inc. , a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms.

Biocept stock opened the day at $0.59 after a previous close of $0.55. The latest price was $0.55 (25-minute delay). Biocept is listed on the NASDAQ, has a trailing 12-month revenue of around USD50.1 million and employs 177 staff.

  • Market capitalization: $9,484,693
  • PEG ratio: -0.04

Back to top


2. Opko Health (OPK)

OPKO Health, Inc. , a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services.

Opko Health stock opened the day at $1.43 after a previous close of $1.38. The latest price was $1.44 (25-minute delay). Opko Health is listed on the NASDAQ, has a trailing 12-month revenue of around USD$1.2 billion and employs 5,767 staff.

  • Market capitalization: $996,764,928
  • PEG ratio: -2.87

Back to top


3. Natera (NTRA)

Natera, Inc. , a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle.

Natera stock opened the day at $117.90 after a previous close of $117.29. The latest price was $120.94 (25-minute delay). Natera is listed on the NASDAQ, has a trailing 12-month revenue of around USD$776 million and employs 2,670 staff.

  • Market capitalization: $4,575,024,640
  • PEG ratio: 0

Back to top


4. Danaher Corporation (DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Danaher Corporation stock opened the day at $269.00 after a previous close of $270.69. The latest price was $270.68 (25-minute delay). Danaher Corporation is listed on the NYSE, has a trailing 12-month revenue of around USD$31.5 billion and employs 81,000 staff.

  • Market capitalization: $192,547,962,880
  • P/E ratio: 27.3685
  • PEG ratio: 3.2365

Back to top


5. IDEXX Laboratories (IDXX)

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments.

IDEXX Laboratories stock opened the day at $488.21 after a previous close of $483.20. The latest price was $504.22 (25-minute delay). IDEXX Laboratories is listed on the NASDAQ, has a trailing 12-month revenue of around USD$3.3 billion and employs 10,000 staff.

  • Market capitalization: $39,793,569,792
  • P/E ratio: 61.1323
  • PEG ratio: 7.2076

Back to top


6. Co-Diagnostics (CODX)

Co-Diagnostics, Inc. , a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications.

Co-Diagnostics stock opened the day at $3.16 after a previous close of $3.15. The latest price was $3.15 (25-minute delay). Co-Diagnostics is listed on the NASDAQ, has a trailing 12-month revenue of around USD$53.2 million and employs 101 staff.

  • Market capitalization: $100,174,000
  • P/E ratio: 6.6122
  • PEG ratio: 0

Back to top


7. DexCom (DXCM)

DexCom, Inc. , a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers.

DexCom stock opened the day at $109.17 after a previous close of $107.71. The latest price was $108.03 (25-minute delay). DexCom is listed on the NASDAQ, has a trailing 12-month revenue of around USD$2.8 billion and employs 6,300 staff.

  • Market capitalization: $41,364,365,312
  • P/E ratio: 237.9778
  • PEG ratio: 11.3373

Back to top


8. Laboratory Corporation of America (LH)

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

Laboratory Corporation of America stock opened the day at $249.09 after a previous close of $250.14. The latest price was $254.94 (25-minute delay). Laboratory Corporation of America is listed on the NYSE, has a trailing 12-month revenue of around USD$15.3 billion and employs 75,000 staff.

  • Market capitalization: $22,337,830,912
  • P/E ratio: 13.4249
  • PEG ratio: 2.0682

Back to top


9. Agilent Technologies (A)

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Agilent Technologies stock opened the day at $156.66 after a previous close of $155.48. The latest price was $155.50 (25-minute delay). Agilent Technologies is listed on the NYSE, has a trailing 12-month revenue of around USD$6.8 billion and employs 18,100 staff.

  • Market capitalization: $44,925,968,384
  • P/E ratio: 36.3014
  • PEG ratio: 2.3596

Back to top


10. Illumina (ILMN)

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.

Illumina stock opened the day at $218.88 after a previous close of $216.52. The latest price was $224.94 (25-minute delay). Illumina is listed on the NASDAQ, has a trailing 12-month revenue of around USD$4.7 billion and employs 9,800 staff.

  • Market capitalization: $33,693,659,136
  • P/E ratio: 48.2432
  • PEG ratio: 4.1783

Back to top


11. Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Thermo Fisher Scientific stock opened the day at $589.51 after a previous close of $587.36. The latest price was $588.32 (25-minute delay). Thermo Fisher Scientific is listed on the NYSE, has a trailing 12-month revenue of around USD$44.2 billion and employs 130,000 staff.

  • Market capitalization: $223,680,900,000
  • P/E ratio: 26.0224
  • PEG ratio: 4.2837

Back to top

How to buy research stocks

Sign up with an online broker or platform to invest in one or more of these research stocks.

  1. Compare share trading platforms. Use our comparison table to narrow down top brokers by fees and bonuses.
  2. Open and fund your brokerage account. You’ll need personal and financial details, like your contact and bank information.
  3. Search for the stock you're interested in. Find the stock by name or ticker symbol, like BIOC or OPK.
  4. Decide on how many to buy. Some brokers will allow you to purchase fractional shares, while others require you to purchase whole shares.
  5. Choose an order type. Invest in the research stocks now with a market order or use a limit order to delay your purchase until the stock reaches your desired price.
  6. Buy the stock. Tap or click the Buy button on your brokerage account. Once you’ve invested in the medical industry, track how your stock performs to decide when it’s time to sell.

Bottom line

While it’s possible to turn a profit investing in research stocks, keep in mind that — like any investment — research stocks are not immune to risk. These stocks are subject to fluctuating conditions — both in the market and in the medical industry, so carefully vet your picks before you invest. And if you’re new to investing, or if it’s been awhile since you’ve taken a critical look at your investing accounts, compare brokers to make sure you’re getting the best features in your trading account.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site